28.07.2020Enanta Pharmaceuticals, Inc., a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that it plans to report its financial results for its fiscal third quarter ended June 30, 2020 after the U.S. markets close on August 4, 2020.
28.07.2020Die US-Regierung wird Zusatzkosten einer deutlich ausgeweiteten Phase-3-Studie für den Corona-Impfstoffkandidaten des Biotechnolgie-Unternehmens Moderna übernehmen. Wegen einer signifikant höheren Anzahl an Probanden benötige das Unternehmen zusätzliche Investitionen im Umfang von bis
28.07.2020Man hat sich lange nicht gesehen, den Kopf durchgelüftet, sich verändert: Die Rückkehr zur Schule nach den Sommerferien war schon immer etwas aufregend. In Zeiten von Corona gilt das nicht mehr nur für Schüler, Eltern und Lehrkräfte. Auch Politiker, Ärzte, Virologen und andere Fachleute
28.07.2020Technavio has been monitoring the respiratory syncytial virus diagnostics market and it is poised to grow by $ 585.17 million during 2020-2024, progressing at a CAGR of almost 10% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.

27.07.2020Mit den Sicherheitskupplungen der Typen SKX-L und SKB bietet die JAKOB Antriebstechnik GmbH eine Sicherheitskupplungsgeneration zur Überlastbegrenzung bzw. zum Kollisionsschutz für indirekte Antriebe vor, die den modernsten Anforderungen gerecht wird.
27.07.2020Heritage Global Inc., an asset services company specializing in financial and capital assets, today announced results from its ongoing monthly Pharmaceutical Sector Sale for July. With over 600 items for sale, the 100% online auction received 45,000 page views, more than 9,500 internet bids and generated in excess of one million dollars in asset sales. Furthermore, over 250 companies registered to
27.07.2020Apic Bio, Inc. today announced the formation of its Scientific Advisory Board (SAB) which includes internationally recognized gene therapy experts. The SAB will provide clinical and scientific expertise to help the Company advance its pipeline and leverage its proprietary silence and replace THRIVE™ platform. Apic’s CEO, John Reilly, MS/MBA, stated, "As we continue to advance our programs, it is critical that we obtain input from individuals with diverse
27.07.2020Stefano Pessina Has Informed the Board of His Decision to Step Down as CEO, to Become Executive Chairman of the Board Once New CEO Is Named / James Skinner Will Step down as Executive Chairman at That Time, and Remain on the Board
27.07.20204D Molecular Therapeutics (4DMT), a clinical-stage leader in the development of precision-guided AAV gene medicines based on directed evolution, announced that the first patient has been dosed in the Phase 1 clinical trial of 4D-110, a Roche-licensed product candidate, delivered by a single intravitreal injection for Choroideremia. Choroideremia is a blinding and currently untreatable X-linked inherited retinal disease.
27.07.2020NTT Research Embraces PHI Lab Scientist-led Paper and Academic Initiatives that Set Firmer Foundation for Neuroscientific Models
Sie sehen Artikel 14101 bis 14110 von insgesamt 23209